Tag:

Nanopatch

Latest Headlines

Latest Headlines

Vaxxas scores $20M to develop needle-free vaccines

February 11, 2015 | By
Vaxxas announced Monday that it raised $20 million in a Series B round, which will be used to advance a series of clinical programs and to develop a pipeline of new vaccine products using the company's needle-free Nanopatch platform.

Merck taps Vaxxas for Nanopatch vaccine delivery

October 10, 2012 | By
Drug giant Merck ($MRK) will team up with Australia's Vaxxas to research the startup's drug-delivery patch that targets vaccine to immunological cells just below the skin's surface.

Start-up Vaxxas lands $16.46M for vaccine nanopatch

August 3, 2011 | By
Australia's Vaxxas has garnered about $16.46 million in venture capital financing to support development of its Nanopatch delivery technology, which the company says could drastically change how
Related Tags
Press Releases
  • Opening Arguments Today in Largest US Pharma Theft Civil Suit
  • Award of Funding for Next Stage of US Department of Defense Programme to Develop Genedrive® Biohazard Identification Tests
  • Men in England to finally have routine access to UK-discovered prostate cancer medicine Zytiga (abiraterone acetate) before chemotherapy
  • Switching to Remsima®▼ (infliximab) from originator has no negative effect on safety or efficacy in 10 real-world studies
  • The Myriad myRisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
  • More Press Releases
Sponsored Links